the CHOP regimen consisting of three chemotherapy drugs (cyclophosphamide, hydroxydoxorubicin, and oncovin) plus a glucocorticoid, either prednisone or prednisolone) achieve complete response rates of 48% to 85%, 3-year overall survival rates of 50% to 64%, and 5 year overall survival rates of 46% to 58%.